Skip to main content
Clinical Trials/NCT01707238
NCT01707238CompletedNot Applicable

Multi-Centre Clinical Evaluation Of Two Daily Disposable Contact Lenses

Coopervision, Inc.7 sites in 1 country100 target enrollmentStarted: October 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
7
Primary Endpoint
Handling

Study Overview

Brief Summary

The purpose of this study is to compare the subjective performance for handling of two daily disposable contact lenses, stenfilcon A and etafilcon A.

Detailed Description

The study is to compare the subjective performance for handling of two daily disposable contact lenses, stenfilcon A and etafilcon A in this cross-over study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Other
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
16 Years to 45 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Be between 16 and 45 years of age (inclusive)
  • •Adapted soft contact lens (CL) wearers (i.e. > 1 month)
  • •Spherical distance CL prescription between -1.00 and -6.00D (inclusive)
  • •Spectacle cylinder ≤0.75D in the least astigmatic eye, ≤1.00D in the other.
  • •Correctable to 6/9 (20/30) in both eyes
  • •Have the use of a mobile phone to send and receive text messages throughout the day for the duration of the study.
  • •Have read, understood and signed the informed consent
  • •Willing to comply with the wear schedule (at least 40 hours per week)
  • •Willing to comply with the study visit schedule

Exclusion Criteria

  • •Any active corneal infection, injury or inflammation
  • •Systemic or ocular allergies, which might interfere with CL wear
  • •Systemic disease, which might interfere with CL wear
  • •Ocular disease, which might interfere with CL wear
  • •Strabismus, amblyopia
  • •Subjects who have undergone corneal refractive surgery and any anterior segment surgery
  • •Subjects with keratoconus or other severe corneal irregularity contraindicating lens wear
  • •Pregnant or lactating
  • •Use of systemic/topical medication contraindicating CL wear
  • •Use of gas permeable contact lenses within the last month
  • •Employees of the investigational site or immediate family members of Investigators
  • •Participation in any concurrent clinical trial or in the last 30 days

Arms & Interventions

stenfilcon A

Experimental

Participants wear a first pair of lenses for two weeks and then crossover and wear an alternate second pair of lenses for two weeks.

Intervention: etafilcon A (Device)

etafilcon A

Active Comparator

Participants wear a first pair of lenses for two weeks and then crossover and wear an alternate second pair of lenses for two weeks.

Intervention: stenfilcon A (Device)

Outcomes

Primary Outcomes

Handling

Time Frame: two weeks and four weeks from baseline visit

Participant's subjective rating for lens handling of Pair #1 surveyed at 2 weeks (+3) days after baseline visit and Pair #2 surveyed at 4 weeks (+3) days after baseline visit. Each pair worn for two weeks daily disposable wear basis (at least 40 hours per week). Lenses worn minimum 2 hours prior to visit. Rated by questionnaires (0-10, 10= very easy).

Satisfaction With Handling

Time Frame: two weeks and four weeks from baseline visit

Participant's subjective rating for overall satisfaction of lens handling of Pair #1 surveyed at 2 weeks (+3) days after baseline visit and Pair #2 surveyed at 4 weeks (+3) days after baseline visit. Each pair worn for two weeks daily disposable wear basis (at least 40 hours per week). Lenses worn minimum 2 hours prior to visit. Rated by questionnaires (5 point Likert scale - Completely Dissatisfied, Somewhat Dissatisfied, Neither, Somewhat Satisfied, Completely Satisfied).

Secondary Outcomes

  • Comfort(two weeks and four weeks from baseline visit)
  • Dryness(two weeks and four weeks from baseline visit)
  • Satisfaction With Dryness(two weeks and four weeks from baseline visit)
  • Satisfaction With Comfort(two weeks and four weeks from baseline visit)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (7)

Loading locations...

Similar Trials